Bayer to invest in childhood cancer trial at the University of Birmingham

Significant funding from Bayer, a global enterprise with core competencies in the life science fields of healthcare and nutrition, is enabling the University of Birmingham’s Cancer Research UK Clinical Trials Unit (CRCTU) to deliver a new study arm of an international clinical trial which aims to identify more effective treatments for a rare type of … Continue reading “Bayer to invest in childhood cancer trial at the University of Birmingham”

Bacterial DNA can be read either forwards or backwards

Bacteria contain symmetry in their DNA signals that enable them to be read either forwards or backwards, according to new findings at BHP founder-member the University of Birmingham which challenge existing knowledge about gene transcription. In all living organisms, DNA code is divided into sections which provide information about a specific process. These must be … Continue reading “Bacterial DNA can be read either forwards or backwards”

University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb

BHP founder-member the University of Birmingham is part of a new industry collaboration launched to accelerate drug discovery projects by fast-tracking research from lab to patient. Birmingham is one of four universities selected by drug development company Evotec SE and global pharmaceutical company Bristol Myers Squibb to be part of the newly formed beLAB1407. Evotec, … Continue reading “University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb”